Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.6611.3414.7129.3720.80

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 8.66 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.66
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.66
-23.63
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹874.6 Cr -0.8% -8.4% 138.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹101,445.0 Cr -5.7% -7.8% -13.2% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-0.8%

-8.4%

138.2%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses